Copy link
Export CSV
Cite this view
HANK Price Transparency. (n.d.).
ATEZOLIZUMAB 1200MG/20ML INJ (CDM 717038370) by State .
PPMan price-transparency data, derived from CMS-required hospital MRFs.
Retrieved November 4, 2026 , from http://ppman.hank.ai/transparency/procedure/717038370/by-state?code_type=CDM
“ATEZOLIZUMAB 1200MG/20ML INJ (CDM 717038370) by State.” HANK Price Transparency ,
http://ppman.hank.ai/transparency/procedure/717038370/by-state?code_type=CDM. Accessed
November 4, 2026 .
“ATEZOLIZUMAB 1200MG/20ML INJ (CDM 717038370) by State,” HANK Price Transparency ,
accessed November 4, 2026 ,
http://ppman.hank.ai/transparency/procedure/717038370/by-state?code_type=CDM.
Source: PPMan price-transparency data, derived from CMS-required hospital
machine-readable files (45 CFR 180). See
methodology .
Print / Save PDF
CDM · across United States
717038370 — Atezolizumab 1200mg/20ml Inj
State-by-state median negotiated rates. Lower bars are cheaper states; the
range bar shows the IQR (25th to 75th percentile within each state).
$21,421
National median
$17,527 – $24,760
IQR (p25 – p75)
7
hospitals filing
1
states
Walking in without insurance?
Cash / self-pay price
Cash median
$16,692
vs. negotiated
-22.1%
Hospitals reporting
7
Cash / self-pay rates apply when you don't run the bill through insurance.
Many hospitals also offer income-based discounts on top of the published
cash price — always ask about a financial-assistance application
before paying.
Median negotiated rate, by state
Ranked by typical (median) negotiated price. Hover for state-level IQR.
Median negotiated rate by state for 717038370 (CDM), with interquartile range
State Median p25 p75
IN $21,421 $17,527 $24,760